Literature DB >> 4049246

Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach.

J C Langer, B Langer, B R Taylor, R Zeldin, B Cummings.   

Abstract

Ninety patients with adenocarcinoma of the extrahepatic bile ducts were treated between 1969 and 1984. Fifty-four tumors involved the upper third, 15 the middle third, and 21 the lower third of the common duct. Twenty-two patients had gallstones and five had inflammatory bowel disease. Forty-three patients had operations before definitive treatment; the diagnosis was made in only 18. Resection was accomplished in 30 patients (33%): 12 of 54 in the proximal third, six of 15 in the middle third, and 12 of 21 in the distal third. The mean survival in patients who underwent resection was 32 months (proximal third, 28 months; middle third, 32 months; lower third, 37 months). Surgical bypass was performed in 28 patients (mean survival 10 months) and intubation alone was performed in 24 patients (mean survival 8 months). Recurrent cholangitis occurred in 56% of intubated patients compared with 26% of patients treated without tubes. Radiation was used with resection and for palliation. Responses were observed, but the complication of radiation duodenitis has limited the dose. An aggressive approach to resection of bile duct tumors is possible with a low operative mortality rate and offers the best opportunity for cure as well as good palliation. Internal bypass is preferable to chronic intubation. The role of radiation therapy in this disease is still not clear.

Entities:  

Mesh:

Year:  1985        PMID: 4049246

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  25 in total

1.  Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience.

Authors:  J I Tsao; Y Nimura; J Kamiya; N Hayakawa; S Kondo; M Nagino; M Miyachi; M Kanai; K Uesaka; K Oda; R L Rossi; J W Braasch; J M Dugan
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Major liver resection for hilar cholangiocarcinoma.

Authors:  S Bengmark; H Ekberg; A Evander; B Klofver-Stahl; K G Tranberg
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

3.  An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center.

Authors:  Elijah Dixon; Charles M Vollmer; Ajay Sahajpal; Mark Cattral; David Grant; Christopher Doig; Al Hemming; Bryce Taylor; Bernard Langer; Paul Greig; Steven Gallinger
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

4.  A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma.

Authors:  T E Bowling; S M Galbraith; A R Hatfield; J Solano; M F Spittle
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

5.  High dose chemoradiation for unresectable hilar cholangiocarcinomas using intensity modulated external beam radiotherapy: a single tertiary care centre experience.

Authors:  Reena Engineer; Shaesta Mehta; Nikhil Kalyani; Suresh Chaudhari; Tejas Dharia; Nitin Shetty; Supriya Chopra; Mahesh Goel; Suyash Kulkarni; Shyam Kishore Shrivastava
Journal:  J Gastrointest Oncol       Date:  2017-02

6.  Resection or palliation: priority of surgery in the treatment of hilar cancer.

Authors:  H Bismuth; D Castaing; O Traynor
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

7.  Bypass procedure for bile duct cancer.

Authors:  K Miyazaki; K Nagafuchi; F Nakayama
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

8.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

9.  Flowcharts for the management of biliary tract and ampullary carcinomas.

Authors:  Shuichi Miyakawa; Shin Ishihara; Tadahiro Takada; Masaru Miyazaki; Kazuhiro Tsukada; Masato Nagino; Satoshi Kondo; Junji Furuse; Hiroya Saito; Toshio Tsuyuguchi; Fumio Kimura; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16

10.  Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study.

Authors:  Kyu-Hyoung Lim; Do-Youn Oh; Eui Kyu Chie; Jin-Young Jang; Seock-Ah Im; Tae-You Kim; Sun-Whe Kim; Sung Whan Ha; Yung-Jue Bang
Journal:  BMC Cancer       Date:  2009-09-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.